<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(41)</volume><submitter>Jedinakova P</submitter><pubmed_abstract>A new methodology for the detection of three model proteases using a multi-purpose peptide probe equipped with three selectively cleavable sites and four fluorophores was developed and studied. The probe was designed as a single-excitation, triple-emission system, allowing for the monitoring of characteristic real-time changes in the fluorescence emission responses of individual fluorophores during enzymatic cleavage. It was labelled with diethylaminocoumarin (DEAC), fluorescein (FL) and Rhodamine B (RhB), forming the DEAC → FL → RhB FRET-cascade, with estimated Förster distances of 3.08 ± 0.02 nm or 3.02 ± 0.02 nm for the DEAC → FL FRET-pair (depending on the DEAC labeling site) and 6.04 ± 0.05 nm for the FL → RhB FRET-pair. Although spectroscopic analyses indicate that photophysical processes other than FRET are involved in the probe, the huge changes in its fluorescence intensities (&lt;i>e.g.&lt;/i>, the fluorescence intensity of the probe for the excitation/emission wavelengths 421 nm/476 nm is 50-fold lower compared to that of the DEAC-only labeled construct, or it is 200-fold lower for 480 nm/521 nm compared to that of the FL-only labeled construct) enable the easy detection of protease activities. In a single-enzyme mode, trypsin, chymotrypsin, and thrombin can be determined according to the ratiometric graphical model at the lowest detectable concentrations of 0.0625 ng mL&lt;sup>-1&lt;/sup>, 0.125 μg mL&lt;sup>-1&lt;/sup>, and 0.0125 U mL&lt;sup>-1&lt;/sup>, respectively. The prepared probe, in combination with selective inhibitors (Kunitz, trypsin inhibitor; chymostatin, chymotrypsin inhibitor; and dabigatran, thrombin inhibitor), was also successfully used for the simultaneous detection of individual proteases in their two-enzyme mixtures. Finally, the probe was studied as a tool for three-protease screening using two selected inhibitors. Unfortunately, a universal model capable of unambiguous confirmation of the three studied enzymes in various combinations of their quantities has not been found.</pubmed_abstract><journal>RSC advances</journal><pagination>34821-34832</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12451675</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A new multi-purpose FRET fluorescent probe for the simultaneous detection of proteases.</pubmed_title><pmcid>PMC12451675</pmcid><pubmed_authors>Barbuscakova Z</pubmed_authors><pubmed_authors>Milicevic D</pubmed_authors><pubmed_authors>Hlavac J</pubmed_authors><pubmed_authors>Kubala M</pubmed_authors><pubmed_authors>Jedinakova P</pubmed_authors></additional><is_claimable>false</is_claimable><name>A new multi-purpose FRET fluorescent probe for the simultaneous detection of proteases.</name><description>A new methodology for the detection of three model proteases using a multi-purpose peptide probe equipped with three selectively cleavable sites and four fluorophores was developed and studied. The probe was designed as a single-excitation, triple-emission system, allowing for the monitoring of characteristic real-time changes in the fluorescence emission responses of individual fluorophores during enzymatic cleavage. It was labelled with diethylaminocoumarin (DEAC), fluorescein (FL) and Rhodamine B (RhB), forming the DEAC → FL → RhB FRET-cascade, with estimated Förster distances of 3.08 ± 0.02 nm or 3.02 ± 0.02 nm for the DEAC → FL FRET-pair (depending on the DEAC labeling site) and 6.04 ± 0.05 nm for the FL → RhB FRET-pair. Although spectroscopic analyses indicate that photophysical processes other than FRET are involved in the probe, the huge changes in its fluorescence intensities (&lt;i>e.g.&lt;/i>, the fluorescence intensity of the probe for the excitation/emission wavelengths 421 nm/476 nm is 50-fold lower compared to that of the DEAC-only labeled construct, or it is 200-fold lower for 480 nm/521 nm compared to that of the FL-only labeled construct) enable the easy detection of protease activities. In a single-enzyme mode, trypsin, chymotrypsin, and thrombin can be determined according to the ratiometric graphical model at the lowest detectable concentrations of 0.0625 ng mL&lt;sup>-1&lt;/sup>, 0.125 μg mL&lt;sup>-1&lt;/sup>, and 0.0125 U mL&lt;sup>-1&lt;/sup>, respectively. The prepared probe, in combination with selective inhibitors (Kunitz, trypsin inhibitor; chymostatin, chymotrypsin inhibitor; and dabigatran, thrombin inhibitor), was also successfully used for the simultaneous detection of individual proteases in their two-enzyme mixtures. Finally, the probe was studied as a tool for three-protease screening using two selected inhibitors. Unfortunately, a universal model capable of unambiguous confirmation of the three studied enzymes in various combinations of their quantities has not been found.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T19:18:41.364Z</modification><creation>2026-05-30T03:06:36.992Z</creation></dates><accession>S-EPMC12451675</accession><cross_references><pubmed>40989513</pubmed><doi>10.1039/d5ra03163j</doi></cross_references></HashMap>